In the last trading session, 14.49 million shares of the Kosmos Energy Ltd (NYSE:KOS) were traded, and its beta was 1.45. Most recently the company’s share price was $1.54, and it changed around -$0.05 or -3.14% from the last close, which brings the market valuation of the company to $736.13M. KOS currently trades at a discount to its 52-week high of $6.33, offering almost -311.04% off that amount. The share price’s 52-week low was $1.38, which indicates that the current value has risen by an impressive 10.39% since then.
Kosmos Energy Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.91. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 4 recommended KOS as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
Kosmos Energy Ltd (NYSE:KOS) trade information
Instantly KOS has showed a red trend with a performance of -3.14% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.7200 on recent trading dayincreased the stock’s daily price by 10.47%. The company’s shares are currently down -54.97% year-to-date, but still down -7.78% over the last five days. On the other hand, Kosmos Energy Ltd (NYSE:KOS) is 1.32% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $5.6, which translates to bulls needing to increase their stock price by 72.5% from its current value. Analyst projections state that KOS is forecast to be at a low of $5.6 and a high of $5.6.
Kosmos Energy Ltd earnings are expected to increase by -92.01% in 2025, but the outlook is negative -4.52% per year for the next five years.
KOS Dividends
Kosmos Energy Ltd’s next quarterly earnings report is expected to be released in June.
FMR LLC, with 8.2472% or 38.89 million shares worth $215.47 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
GMO TRUST-GMO Resources Fund and Advisor Managed Portfolios-Patient Opportunity Trust were the top two Mutual Funds as of Feb 28, 2025 . The former held 27.17 shares worth $41.84 million, making up 5.68% of all outstanding shares. On the other hand, Advisor Managed Portfolios-Patient Opportunity Trust held roughly 14.0 shares worth around $21.56 million, which represents about 2.93% of the total shares outstanding.
